Daniel Salain - Jan 20, 2023 Form 4 Insider Report for Aceragen, Inc. (ACGN)

Signature
/s/ John J. Kirby, Attorney-in-Fact
Stock symbol
ACGN
Transactions as of
Jan 20, 2023
Transactions value $
$0
Form type
4
Date filed
2/2/2023, 07:12 PM
Previous filing
Jan 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACGN Stock Options (Right to Buy) Award $0 +25.4K $0.00 25.4K Jan 20, 2023 Common Stock 25.4K $5.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award was granted under the Issuer's 2022 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 20, 2023. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 20, 2024 (first anniversary of the date of grant) and the balance vests in thirty-six equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.